Back
Altamira Therapeutics Vs. IGC Pharma Industry Stock Comparison
Sell
13
CYTO
Altamira Therapeutics
Last Price:
0.44
Seasonality Move:
19.63%
Sell
37
IGC
IGC Pharma
Last Price:
0.36
Seasonality Move:
-9.08%
Sell
13
Altamira Therapeutics (CYTO)
is a Sell
Is Altamira Therapeutics a Buy, Sell or Hold?
- The current Altamira Therapeutics [CYTO] share price is $0.42. The Score for CYTO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- CYTO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.36. The Score for IGC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTO Stock Price Chart
What is Altamira Therapeutics's stock price today?
-
The Altamira Therapeutics share price today is $0.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTO is experiencing selling pressure, which indicates risk of future bearish movement.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing slight buying pressure.
CYTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 34.45 | Sell |
Chaikin Money Flow: | -46795 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.43 - 0.53) | Sell |
Bollinger Bands (100): | (0.53 - 1.09) | Sell |
IGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 44.68 | Sell |
Chaikin Money Flow: | -31963 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.36 - 0.4) | Sell |
Bollinger Bands (100): | (0.35 - 0.43) | Sell |
CYTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.43 | Sell |
20-day SMA: | 0.47 | Sell |
50-day SMA: | 0.57 | Sell |
200-day SMA: | 1.24 | Sell |
8-day EMA: | 0.44 | Sell |
20-day EMA: | 0.47 | Sell |
50-day EMA: | 0.59 | Sell |
200-day EMA: | 4.01 | Sell |
IGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Buy |
20-day SMA: | 0.37 | Sell |
50-day SMA: | 0.37 | Sell |
200-day SMA: | 0.41 | Sell |
8-day EMA: | 0.35 | Buy |
20-day EMA: | 0.36 | Sell |
50-day EMA: | 0.38 | Sell |
200-day EMA: | 0.39 | Sell |
Altamira Therapeutics Earnings Growth & CYTO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.76 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Altamira Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IGC Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |